2,2,2-Trifluoro-1-(pyridin-3-yl)ethanamine hydrochloride, 95.0%, 1g

2-Nitro-4-(trifluoromethoxy)benzoic acid, 95%, 1g

2-Amino-3,5-dibromopyridine, 98.0%, 25g

Chloral hydrate, min. 98%, for synthesis, 500 g, plastic packaging.

1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide, 98%, 10mg

4-Hexadecylaniline, 97%, 1g

2-Methyl-[1,3]oxazolo[4,5-c]pyridine, 97%, 100mg

4-propyl-5-(2-thienyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

Methyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6-carboxylate, 95.0%, 1g

2-(3-Methoxyphenyl)propan-2-amine hydrochloride, 500mg

3-(m-Tolyl)-1H-pyrazole, 95.0%, 1g

5-Methylcyclohexane-1,3-dione, 98.0%, 100g

Methyl 16-hydroxyhexadecanoate, 98%, 100mg